Ergotamine/caffeine
Pharmaceutical product
From Wikipedia, the free encyclopedia
Ergotamine/caffeine, sold under the brand name Cafergot among others, is a fixed-dose combination medication used for the treatment of migraine. It contains ergotamine, as the tartrate, an alpha adrenergic blocking agent; and caffeine, a cranial vasoconstrictor.[3]
Ergotaminevasoconstrictor, neurotransmitter agonist and antagonist
Caffeinevasoconstrictor, phosphodiesterase inhibitor
Trade namesCafergot, Migergot, others
| Combination of | |
|---|---|
| Ergotamine | vasoconstrictor, neurotransmitter agonist and antagonist |
| Caffeine | vasoconstrictor, phosphodiesterase inhibitor |
| Clinical data | |
| Trade names | Cafergot, Migergot, others |
| AHFS/Drugs.com | Multum Consumer Information |
| MedlinePlus | a601048 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth, rectal |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Ergotamine/caffeine is available as a generic medication.
Medical uses
Mechanism of action
Adverse effects
Because the vasoconstrictive effects of ergotamine and caffeine are not selective for the brain, adverse effects due to systemic vasoconstriction can occur. Cold feet or hands, angina pectoris, myocardial infarction,[6] or dizziness are some examples.
It has also been shown to be associated with mitral valve stenosis. [7]